Carcinoma, Hepatocellular: all 3,251 studies
Page 20 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Cytokine Change in Hepatocellular Carcinoma Treated by Thermal AblationCompletedNCT04555265Not applicable
- Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular CarcinomaCompletedNCT04553458
- Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After TreatmentStatus unknownNCT04552236
- NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ TumorsStatus unknownNCT04550663Phase 1
- HepATocellular Cancer Hcv Therapy StudyWithdrawnNCT04546802Phase 3
- The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular CarcinomaCompletedNCT04542837Phase 2
- A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILsStatus unknownNCT04538313Phase 1/2
- TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 TrialStatus unknownNCT04531228Not applicable
- Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT04526080Phase 2
- Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver CancerStatus unknownNCT04523662Phase 2
- Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular CarcinomaStatus unknownNCT04523467Not applicable
- Dose Escalation Study of Cabozantinib for Advanced HCC Patients with Preserved Liver FunctionCompletedNCT04522908Phase 2
- Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCCActive, not recruitingNCT04522544Phase 2
- A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor CellsStatus unknownNCT04521491Not applicable
- Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular CarcinomaActive, not recruitingNCT04521153Phase 2/3
- To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver CancerTerminatedNCT04520906Not applicable
- TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCCCompletedNCT04518852Phase 2
- Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical TrialStatus unknownNCT04518774Early Phase 1
- The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.Status unknownNCT04513119
- CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated CirrhosisStatus unknownNCT04512833
- Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line TreatmentCompletedNCT04511455Phase 2
- Effects of Anesthetic Methods on Hepatic Cancer Cell Function in VitroCompletedNCT04510935Not applicable
- Liver Cancer Registry PlatformActive, not recruitingNCT04510740
- GPC3-CAR-T Cells for the Hepatocellular CarcinomaSuspendedNCT04506983Phase 1
- Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC RecurrenceStatus unknownNCT04506398
- Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT04503902Phase 1/2
- Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)TerminatedNCT04502082Phase 1
- Role of CEUS as a Secondary Diagnostic ModalityStatus unknownNCT04494022Not applicable
- TACE Combined With Lenvatinib for Unresectable Hepatocellular CarcinomaStatus unknownNCT04490694Phase 2
- PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)CompletedNCT04484636Not applicable
- Study of TACE Combined With Camrelizumab in the Treatment of HCC PatientsActive, not recruitingNCT04483284Phase 2
- Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT04479527Phase 2
- Optimization for Regorafenib in HCCTerminatedNCT04476329Phase 2
- RFA Using Gradual RF Energy Delivery Mode With Octopus ElectrodesStatus unknownNCT04471272Not applicable
- A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCCWithdrawnNCT04465734Phase 3
- Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCCCompletedNCT04459468
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersActive, not recruitingNCT04459273Phase 1
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
- A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver FunctionStatus unknownNCT04454762Phase 2
- LiverMultiScan Analysis of MRI Scans in HCCCompletedNCT04451603
- A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular CarcinomaCompletedNCT04444167Phase 1/2
- Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCCStatus unknownNCT04443309Phase 1/2
- To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.Status unknownNCT04443049Not applicable
- Efficacy and Safety of Cabozantinib in Patients With Hepatocellular CarcinomaStatus unknownNCT04435977Phase 2
- Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint InhibitorsTerminatedNCT04428437
- Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver TransplantStatus unknownNCT04425226Not applicable
- Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic TumorsCompletedNCT04420026Not applicable
- Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC PatientsCompletedNCT04418401Phase 1
- TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.Status unknownNCT04417764Phase 1
- Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver TransplantationCompletedNCT04415567
- Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFPCompletedNCT04412161
- A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular CarcinomaStatus unknownNCT04411706Phase 2
- Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular CarcinomaCompletedNCT04401813Phase 1
- Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular CarcinomaCompletedNCT04393220Phase 2
- A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
- Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCCCompletedNCT04391348Not applicable
- Optimizing Y90 Therapy for Radiation LobectomyActive, not recruitingNCT04390724
- SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTTStatus unknownNCT04387695Phase 3
- Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular CarcinomaStatus unknownNCT04386772Not applicable
- Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsCompletedNCT04374877Phase 1
- AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular CarcinomaStatus unknownNCT04368182Phase 1
- Lenvatinib Combined Toripalimab in Advanced Hepatocellular CarcinomaStatus unknownNCT04368078Phase 2
- COVID-19 Infection in Patients With Hepatocellular CarcinomaActive, not recruitingNCT04367805
- A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04344158Phase 3
- A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCCStatus unknownNCT04331743Phase 1
- RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet ElectrodesStatus unknownNCT04331184Not applicable
- "Cocktail" Therapy for Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT04317248Phase 2
- Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver TumorsTerminatedNCT04315883
- GEN2 Directed Cancer Immunotherapy TrialCompletedNCT04313868Phase 1
- Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular CarcinomaCompletedNCT04310709Phase 2
- PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver CancerCompletedNCT04310540Early Phase 1
- The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular CarcinomaCompletedNCT04303286
- The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive TreatmentStatus unknownNCT04299919
- TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular CarcinomaCompletedNCT04297280Phase 2
- A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCCCompletedNCT04297254Phase 4
- SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular CarcinomaStatus unknownNCT04297202Phase 2
- The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular CarcinomaCompletedNCT04296058
- Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus InfectionCompletedNCT04294498Phase 2
- Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With CirrhosisCompletedNCT04288323Phase 4
- PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCCStatus unknownNCT04273100Phase 2
- Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCCSuspendedNCT04268888Phase 2/3
- Arterial Base Fluorescence Segmental Positive StainingCompletedNCT04266548Not applicable
- Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in DiameterCompletedNCT04264962Early Phase 1
- Characterization of Methylation Patterns in Hepatocellular CarcinomaTerminatedNCT04264754
- Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative TreatmentCompletedNCT04264260Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersTerminatedNCT04260802Phase 1/2
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsCompletedNCT04242199Phase 1
- Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCCStatus unknownNCT04241523Phase 2
- A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular CarcinomaStatus unknownNCT04239781
- Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT04237740Phase 3
- P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular CarcinomaStatus unknownNCT04233840Phase 1/2
- BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.WithdrawnNCT04231929Not applicable
- Multicenter Study to Evaluate a New Robotic Device for Image-guided Percutaneous Needle PlacementCompletedNCT04230642Not applicable
- DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular CarcinomaStatus unknownNCT04229355Phase 3
- Efficacy and Safety of Lenvatinib as an Adjuvant Therapy for Hepatocellular CarcinomaStatus unknownNCT04227808Phase 2
- Longitudinal Immune-phenotyping of HCC Following MK-3475Active, not recruitingNCT04224480Phase 1
- Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCCStatus unknownNCT04221347
- Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.Active, not recruitingNCT04220944Phase 1
- Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04220151
- Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery RecurrenceStatus unknownNCT04213118Phase 2